Bosch Healthcare Solutions starts US distribution
FDA clearance for Vivatmo pro
Picture: Methapharm and Bosch representatives present Vivatmo pro at the ATS Congress 2024 in San Diego, California.
The Vivatmo pro FeNO measuring device is now available on the US market. At the end of February 2024, the Food and Drug Administration (FDA) cleared the Vivatmo pro for US distribution. Sales to healthcare professionals will be handled by Bosch's new distribution partner Methapharm.
"Methapharm is the ideal partner for our entry into the US market," states Marc Meier, General Manager of Bosch Healthcare Solutions. "We work with great passion and engineering skills to make everyday life in the healthcare sector better, step by step. Methapharm's dialog-based approach ensures that we have access to our US customers at eye level and understand their needs. This helps us to tailor our high-precision sensor technology and the resulting solutions to the requirements of the market. And it fits our company philosophy perfectly: Invented for Life."
This website contains general product information about the Vivatmo system from Bosch. Not all products and their functions mentioned here are approved in every regional market. For a detailed description of the products and features as well as information on intended and safe use, please refer to your locally authorized Bosch distribution partner and the instructions for use that are valid for your country.